Žiga Jakopin

24PUBLICATIONS
43CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designGlycoconjugatesToxicology (incl. clinical toxicology)Nanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 22, 2026
Conjugated NOD1-Centered Dual Agonists Exhibit Modest In Vitro Immunomodulation but Potent In Vivo Adjuvanticity.

|Jun 13, 2026
Beyond α-GalCer: Medicinal Chemistry Insights Driving Structural Evolution of CD1d Ligands.

|May 06, 2026
Probing Immune Signatures of Conjugated Pattern Recognition Receptor Ligands Identifies Chimeras with Potent Adjuvant and Antitumor Activities.

|Apr 06, 2026
Halogenated Phenolic Ingredients of Household and Personal Care Products Modulate Thyroid Receptor Signaling.

Veronika Weiss, Nuša Jud, Martina Gobec

|Sep 08, 2025
Modulating Receptor Activity, Immune Response, and Kinetic Solubility: The Impact of Linker Chemistry in Conjugated NOD2/TLR4 Agonists.

Emiliano Paradiso, Špela Janež, Žiga Jakopin

|Oct 10, 2024
Linker Chemistry and Connectivity Fine-Tune the Immune Response and Kinetic Solubility of Conjugated NOD2/TLR7 Agonists.

Špela Janež, Samo Guzelj, Žiga Jakopin

Pageof 4

Frequent Collaborators

5 joint publications

Tihomir Tomašič

4 joint publications

Marko Anderluh

3 joint publications

Ulf J Nilsson

3 joint publications

Hakon Leffler